‘We’re increasingly seeing incidents where alert fatigue has been identified as a contributing factor. It’s not that there wasn’t an alert in place, but that it was lost among the other alerts the clinician saw,’ Prof Baysari says.
Importation of nicotine e-cigarettes to be banned
From next Wednesday, proposed customs regulations will prohibit the importation of e-cigarettes containing vaporiser nicotine (nicotine liquids and salts) and nicotine-containing refills.
Pharmacists and Australia’s COVID-19 vaccination policy
Pharmacies are likely to play a role in COVID-19 vaccination, and people at increased risk of exposure, including health and aged care workers, will be among the first to receive a vaccine.
First vaccine appointments for 5–11 years run smoothly, amid cancellations
Community pharmacists were some of the first to vaccinate children aged 5–11 against COVID-19 this week.
Five practice pointers for dispensing Paxlovid
Pfizer’s COVID-19 treatment Paxlovid (nirmatrelvir and ritonavir) will be listed on the Pharmaceutical Benefits Scheme (PBS) from 1 May. Here’s what pharmacists need to know.
New PBS listing could change psoriasis treatment
Two additional targeted biologicals for severe chronic plaque psoriasis are now listed on the Pharmaceutical Benefits Scheme (PBS), offering relief for adults with the...
A new way to discuss inhaler technique
By distinguishing between the two different types of inspiratory flow rates, this new label could help to improve inhaler technique.
